Skip to content

Incyte INCY EV / EBITDA

EV / EBITDA at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
12×+0.4×
Pfizer logo
PfizerPFE
12.9×
Gilead Sciences logo
Gilead SciencesGILD
17.5×-0.7×
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
Amgen logo
AmgenAMGN
15.9×-1.3×
Biogen logo
BiogenBIIB
11.2×+2.8×

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.8%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$19.78B+59.9%
Enterprise value$16.35B+55.9%
P/E13.8×-568×
P/S3.7×+0.9×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0.0×
Current ratio3.7×+1.6×

Where this comes from

Calculated from Incyte’s reported figures.

Based on the most recent quarter.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's EV / EBITDA?
Incyte (INCY) reported EV / EBITDA of 9× in Q1 2026.
How has Incyte's EV / EBITDA changed year-over-year?
Incyte's EV / EBITDA decreased by 75.8% year-over-year, from 37.1× to 9×.
What is the long-term trend for Incyte's EV / EBITDA?
Over 3 years (2022 to 2025), Incyte's EV / EBITDA has grown at a -7.5% compound annual growth rate (CAGR), from 82.6× to 65.3×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.